Abstract:During tumor treatment, effective imaging diagnosis can monitor the biological distribution of nanomaterials in vivo, so as to reveal the therapeutic effect of nanomaterials and provide comprehensive information of tumor tissue. In conventional cancer therapy, nanomaterials that fail to distinguish between tumor cells and normal cells often lead to adverse side effects and higher systemic toxicity. Therefore, more and more attention has been paid to the development of multifunctional nano-platform for a variety of biomedical applications. Aptamers are single-stranded oligonucleotide that can specifically recognize their substrates, such as metal ions, small molecule, proteins and even cells. Owing to their high specificity, aptamers can endow the delivery system with robust targeting ability and enhance the enrichment of drugs and imaging agents in tumor tissues, holding great promise in molecular diagnosis and cancer therapy. Here, we designed a NIR-activated optical imaging and target-recognition multifunctional nanoplatforms by the capsulation of poly(acrylic acid) (PAA) coated NaYF4:Yb/Er/Nd@NaYF4:Nd upconversion nanoparticles (UCNPs-PAA) within aptamer-guided liposome (Apt-Lip) to form UCNPs@Apt-Lip. Transmission electron microscopy (TEM) images showed that the composite nanomaterials had a uniform spherical structure, and the UCNPs nanoparticles were successfully loaded into the liposome modified by AS1411 aptamer, and the monodispersity of nanoparticles was good. The Dynamic light scattering (DLS) detected that the hydrated particle size of UCNPs@Apt-Lip modified by AS1411 aptamer changed from 165.6 nm to 209.5 nm, and the zeta potential (-22.7 mV) was lower than UCNPs@Lip (-20.5 mV), which further confirmed that the AS1411 aptamer was successfully connected to the surface of UCNPs@lip. Flow cytometry and targeted cell fluorescence imaging experiments show that UCNPs@Apt-Lip nanostructure has strong ability of target recognition and fluorescence imaging to MCF-7 cells. With the unique properties of movable cores, interstitial hollow spaces, and the functionality of shells, we believe that multifunctional nanoplatforms will have great potential for application in various fields, such as photocatalysis, nanoreactors, drug delivery and tumor treatment.

Cancer-targeted Nucleic Acid Delivery and Quantum Dot Imaging Using EGF Receptor Aptamer-conjugated Lipid Nanoparticles

Anti-EGF Receptor Aptamer-Guided Co-Delivery of Anti-Cancer siRNAs and Quantum Dots for Theranostics of Triple-Negative Breast Cancer

Novel Lipid Nanocomplex Co-Carrying Bcl2 siRNA and Quantum Dots for EGF Receptor-Targeted Anti-Cancer Theranosis

A Novel Cancer Nanotheranostics System Based on Quantum Dots Encapsulated by a Polymer-Prodrug with Controlled Release Behaviour

Enzymatic interlocking aptamer-micelles for enhanced cellular internalization and nucleus-targeted cancer phototherapy

High Transfection Efficiency of Quantum Dot-Antisense Oligonucleotide Nanoparticles in Cancer Cells Through Dual-Receptor Synergistic Targeting

Aptamer Guided Liposomes Loaded Upconversion Nanoparticles for Targeted Imaging

A pH-Responsive Nanoplatform Based on Fluorescent Conjugated Polymer Dots for Imaging-Guided Multitherapeutics Delivery and Combination Cancer Therapy

Dendrimer-triglycine-EGF Nanoparticles for Tumor Imaging and Targeted Nucleic Acid and Drug Delivery

Transformation of cell-derived microparticles into quantum-dot-labeled nanovectors for antitumor siRNA delivery

Single Chain Epidermal Growth Factor Receptor Antibody Conjugated Nanoparticles for in Vivo Tumor Targeting and Imaging

Quantum dot− aptamer conjugates for synchronous cancer imaging, therapy, and sensing of drug delivery based on bi-fluorescence resonance energy transfer

Targeted Anti-Cancer Therapy: Co-Delivery of VEGF siRNA and Phenethyl isothiocyanate (PEITC) via cRGD-Modified Lipid Nanoparticles for Enhanced Anti-Angiogenic Efficacy

Effective Integration of Targeted Tumor Imaging and Therapy Using Functionalized InP QDs with VEGFR2 Monoclonal Antibody and Mir-92A Inhibitor

Graphene quantum dot formulation for cancer imaging and redox-based drug delivery

Enzyme-Responsive Cell-Penetrating Peptide Conjugated Mesoporous Silica Quantum Dot Nanocarriers for Controlled Release of Nucleus-Targeted Drug Molecules and Real-Time Intracellular Fluorescence Imaging of Tumor Cells

Drug Delivery: Enzyme‐Responsive Cell‐Penetrating Peptide Conjugated Mesoporous Silica Quantum Dot Nanocarriers for Controlled Release of Nucleus‐Targeted Drug Molecules and Real‐Time Intracellular Fluorescence Imaging of Tumor Cells (adv. Healthcare Mater. 8/2014)

Membrane‐destabilizing ionizable lipid empowered imaging‐guided siRNA delivery and cancer treatment

Au:Cdhgte Quantum Dots for in Vivo Tumor-Targeted Multispectral Fluorescence Imaging

Redox-Activated Light-Up Nanomicelle for Precise Imaging-Guided Cancer Therapy and Real-Time Pharmacokinetic Monitoring

Synthesis of fluorescent dye-doped silica nanoparticles for target-cell-specific delivery and intracellular microRNA imaging.